Difference between revisions of "Kuba K, et al, Nat Med (2005), cited as Ref 21 in DOI:10.1007/s11886-020-01292-3 (Q10530)"
Jump to navigation
Jump to search
(Created claim: First Author string (P149): Kuba K, #quickstatements; #temporary_batch_1592502690680) |
(Created claim: Second Author string (P150): Imai Y, #quickstatements; #temporary_batch_1592502960189) |
||
| Property / Second Author string | |||
| + | Imai Y | ||
| Property / Second Author string: Imai Y / rank | |||
| + | Normal rank | ||
Revision as of 17:56, 18 June 2020
Cited in: "Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response" Research article published in Curr Cardiol Rep; 2020 04 21 ; 22 (5) 32.
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Kuba K, et al, Nat Med (2005), cited as Ref 21 in DOI:10.1007/s11886-020-01292-3
|
Cited in: "Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response" Research article published in Curr Cardiol Rep; 2020 04 21 ; 22 (5) 32.
|
Statements
Q10356 (Deleted Item)
0 references
A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury (English)
0 references
Kuba K
0 references
Imai Y
0 references
